Location History:
- Zurich, CH (2010)
- Zürich, CH (2011)
Company Filing History:
Years Active: 2010-2011
Title: The Innovative Contributions of Peter Sonderegger
Introduction
Peter Sonderegger is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of neurobiology, particularly through his innovative methods for determining neurotrypsin inhibitors. His work has implications for treating various diseases associated with synaptic deficiencies.
Latest Patents
Peter Sonderegger holds a patent for a method that determines whether a compound is a neurotrypsin inhibitor. This method involves incubating a compound with neurotrypsin and a protein or peptide comprising agrin in an aqueous buffer solution. The amount of cleavage of agrin is then measured. This invention is crucial for identifying inhibitors that can be used in the treatment and prophylaxis of diseases such as skeletal muscle atrophy, schizophrenia, and cognitive disturbances. He has 1 patent related to this innovative method.
Career Highlights
Throughout his career, Peter Sonderegger has worked with esteemed institutions, including the University of Zurich and Neurotune AG. His research has focused on neurobiology and the development of therapeutic strategies for neurological disorders. His contributions have been recognized in the scientific community, and he continues to be an influential figure in his field.
Collaborations
Peter Sonderegger has collaborated with notable colleagues, including Stefan Hettwer and Marc F. Bolliger. These collaborations have furthered research in neurobiology and have led to advancements in understanding neurotrypsin and its inhibitors.
Conclusion
Peter Sonderegger's innovative work in determining neurotrypsin inhibitors showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various neurological disorders significantly.